Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001193125-26-043626
Filing Date
2026-02-10
Accepted
2026-02-10 06:36:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 14D9/A d922641dsc14d9a.htm SC 14D9/A 16245
  Complete submission text file 0001193125-26-043626.txt   17927
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filed by) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Subject) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-80035 | Film No.: 26613400
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)